Bill Donaldson

Bill Donaldson has extensive experience in the pharmaceutical industry, with a focus on Regulatory Affairs. Bill currently holds the position of SVP Regulatory Affairs and Quality Assurance at Vincerx Pharma since March 2021. Prior to this, they served as the VP Regulatory Affairs (and Quality Assurance, ad interim) at Sierra Oncology from April 2018 to March 2021.

Before joining Sierra Oncology, Bill worked as the VP Regulatory Affairs at Acerta Pharma B.V. from August 2014 to April 2018. Bill also held the position of Senior Director Regulatory Affairs at Gilead Sciences from March 2013 to August 2014. Prior to that, they worked as a Director at EMD Serono, Inc. from April 2011 to March 2013.

Bill's career in Regulatory Affairs began at Pfizer Inc., where they served as Snr. Director, Regulatory Affairs from January 2004 to June 2012.

Bill Donaldson has a Doctor of Philosophy (PhD) degree in Immunology from Cornell University. Prior to this, they pursued a Bachelor of Veterinary Science (BVSc) degree in Veterinary Medicine at The University of Queensland from 1977 to 1982.